• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

2023 Starts With Psychedelic Decrim Measures In Several States

Jason Najum by Jason Najum
January 13, 2023
in Law & Politics
Reading Time: 2 mins read
A A
Toronto Board of Health Votes to Decriminalize Drugs

2023 has started off as a good year for psychedelic decriminalization.

The year started with Oregon implementing its legalized psilocybin therapy programs, and a few days later, the state of New York announced a bill to legalize some psychedelics for adults 21 and older.

Continuing the trend, we have several other states introducing psychedelic decriminalization measures.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Washington State psychedelic decriminalization

Senators in Washington State have come together in a bipartisan group to introduce a bill that would legalize psilocybin services for adults.

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

The “Psilocybin Services Wellness and Opportunity Act” was filed with 20 cosponsors from both pirates, proposing to legalize and regulate psilocybin for adults 21 and older.

The new bill would: “facilitate the establishment of safe, legal, and affordable psilocybin service centers to provide citizens of Washington who are at least 21 years of age with opportunities for supported psilocybin experiences for wellness and personal growth..”

“…reduce the prevalence of behavioral health disorders among adults in this state by providing for supported adult use of psilocybin under the supervision of a trained and licensed psilocybin service facilitator,” it says.

The bill already has 20 Senators on board.

The Psilocybin Wellness and Opportunity Act is once again 🔔 LIVE! With🚨*20*🚨 co-sponsors! This is huge.
Can we get 1k comments in support of the bill? 📢https://t.co/6bnsJITwDc
Like and share, don't let the Washington State gov ignore this! #waleg

— Psychedelic Medicine Alliance WA (@pma_wa) January 11, 2023

 

Illinois Psychedelic Therapy Program

Verified Lasix For Sale

Illinois started its 2023 legislative session with a proposal for psychedelic reform. The first bill introduced in 2023 was the Compassionate Use and Research of Entheogens Act, or the “CURE Act”.

The legislation, introduced by Democrat La Shawn Ford, would establish a regulated psychedelic therapy program, allowing adults ages 18 and older to legally seek psychedelic therapy from a trained facilitator at a licensed service center. The bill also removes criminal penalties for psilocybin, the psychoactive substance found in psychedelic mushrooms.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

From Ford’s press release: “I’ve been seeing more and more legitimate scientific evidence, including information coming from the FDA, showing that psychedelic therapy is not only safe, but also very effective, particularly for the toughest patients for whom other treatments have not worked. At the same time, I am also hearing from patients and from their medical providers, that Illinoisans should have access to these exciting new treatment options…”

 

 

Virginia seeks magic mushroom reform

A new bill introduced by Del. Dawn Adams (D-Richmond) would legalize citizens of Virginia to possess psilocybin with a valid prescription or medical practitioner’s order “for treatment of refractory depression or post-traumatic stress disorder or to ameliorate end-of-life anxiety.”

The bill would also lower punishment for carrying unprescribed psilocybin from 10 years in prison to a Class 2 misdemeanor and with up to 30 days in jail.

Lawmakers began debating the proposal during the launching of the 2023 Virginia General Assembly session this week.

Tags: Decriminalization
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post
Veterans at Forefront of the Psychedelic Medicine Movement

Veterans at Forefront of the Psychedelic Medicine Movement

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.